
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
POPX2 CRISPR/Cas9 KO Plasmid (h) | sc-406536 | 20 µg | $397.00 |
PPM1F encodes the serine/threonine protein phosphatase POPX2 (PP2C family), a regulator of phosphorylation-dependent signaling that counterbalances kinase pathways controlling cytoskeletal dynamics and cell-cycle–associated processes. POPX2 has been linked to modulation of actin remodeling and cell motility through dephosphorylation of select substrates within Rho GTPase–coupled and stress-responsive networks, integrating cues that influence adhesion and directional migration. By tuning these signaling nodes, POPX2 can shape cellular responses such as proliferation, survival, and invasive behavior in model systems. Dysregulated phosphatase activity and altered PPM1F/POPX2 expression have been reported in contexts relevant to cancer biology and other disorders where aberrant phosphorylation signaling perturbs tissue homeostasis.
POPX2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PPM1F gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PPM1F together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PPM1F open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish POPX2 protein expression.
This CRISPR knockout system enables efficient generation of PPM1F-deficient cell models for investigation of POPX2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.